Multiple-Hit Hypothesis in Parkinson's Disease: LRRK2 and Inflammation.

IBD LRRK2 Parkinson’s disease inflammation neuroinflammation

Journal

Frontiers in neuroscience
ISSN: 1662-4548
Titre abrégé: Front Neurosci
Pays: Switzerland
ID NLM: 101478481

Informations de publication

Date de publication:
2020
Historique:
received: 31 01 2020
accepted: 27 03 2020
entrez: 16 5 2020
pubmed: 16 5 2020
medline: 16 5 2020
Statut: epublish

Résumé

The multiple hit hypothesis for Parkinson's disease (PD) suggests that an interaction between multiple (genetic and/or environmental) risk factors is needed to trigger the pathology. Leucine-Rich Repeat Kinase 2 (LRRK2) is an interesting protein to study in this context and is the focus of this review. More than 15 years of intensive research have identified several cellular pathways in which LRRK2 is involved, yet its exact physiological role or contribution to PD is not completely understood. Pathogenic mutations in LRRK2 are the most common genetic cause of PD but most likely require additional triggers to develop PD, as suggested by the reduced penetrance of the LRRK2 G2019S mutation. LRRK2 expression is high in immune cells such as monocytes, neutrophils, or dendritic cells, compared to neurons or glial cells and evidence for a role of LRRK2 in the immune system is emerging. This has led to the hypothesis that an inflammatory trigger is needed for pathogenic LRRK2 mutations to induce a PD phenotype. In this review, we will discuss the link between LRRK2 and inflammation and how this could play an active role in PD etiology.

Identifiants

pubmed: 32410948
doi: 10.3389/fnins.2020.00376
pmc: PMC7199384
doi:

Types de publication

Journal Article Review

Langues

eng

Pagination

376

Informations de copyright

Copyright © 2020 Cabezudo, Baekelandt and Lobbestael.

Références

Hum Mol Genet. 2016 Aug 15;25(16):3515-3523
pubmed: 27378696
NPJ Parkinsons Dis. 2017 Mar 28;3:11
pubmed: 28649611
Brain. 2018 Jun 1;141(6):1753-1769
pubmed: 29800472
J Neurochem. 2007 Jan;100(2):368-81
pubmed: 17101029
Front Neurosci. 2019 Dec 17;13:1352
pubmed: 31920513
Mov Disord. 2017 Mar;32(3):423-432
pubmed: 27911006
J Neurol Neurosurg Psychiatry. 2010 Aug;81(8):890-1
pubmed: 20462916
Brain Res. 2007 Jun 25;1155:208-19
pubmed: 17512502
Biochem Soc Trans. 2019 Dec 20;47(6):1581-1595
pubmed: 31769472
J Neuroinflammation. 2015 Dec 09;12:230
pubmed: 26646749
Neurosci Lett. 1996 Jun 14;211(1):13-6
pubmed: 8809836
Nat Genet. 2010 Sep;42(9):781-5
pubmed: 20711177
Ann Neurol. 2006 Apr;59(4):714-9
pubmed: 16532471
Lancet. 2011 Feb 19;377(9766):641-9
pubmed: 21292315
Lancet. 1982 Oct 16;2(8303):860-4
pubmed: 6126720
J Parkinsons Dis. 2019;9(1):121-139
pubmed: 30452424
Neurosci Lett. 1994 Jan 3;165(1-2):208-10
pubmed: 8015728
Nat Genet. 2015 Sep;47(9):979-986
pubmed: 26192919
Hum Mol Genet. 2014 Aug 15;23(16):4201-14
pubmed: 24682598
J Neural Transm (Vienna). 2011 May;118(5):795-808
pubmed: 21552986
Ann Neurol. 2005 Dec;58(6):963-7
pubmed: 16240369
PLoS One. 2011;6(6):e21519
pubmed: 21738687
Front Neurol. 2019 Jun 04;10:574
pubmed: 31214110
J Biol Chem. 2015 Aug 7;290(32):19433-44
pubmed: 26078453
Nat Commun. 2015 Sep 14;6:8255
pubmed: 26365310
Neuroscience. 2017 Jan 6;340:398-410
pubmed: 27840232
J Neurosci. 2015 Apr 1;35(13):5271-83
pubmed: 25834052
Sci Transl Med. 2018 Oct 31;10(465):
pubmed: 30381408
Brain Pathol. 1998 Oct;8(4):625-40
pubmed: 9804372
Ann Neurol. 2006 Nov;60(5):557-69
pubmed: 17120249
Acta Neuropathol. 2019 Jun;137(6):961-980
pubmed: 30927072
J Clin Med. 2019 Aug 08;8(8):
pubmed: 31398905
Sci Transl Med. 2019 Sep 25;11(511):
pubmed: 31554740
Nat Rev Neurol. 2018 Mar;14(3):133-150
pubmed: 29377008
Stem Cell Reports. 2019 Jan 8;12(1):29-41
pubmed: 30595548
Mov Disord. 2017 Oct;32(10):1432-1438
pubmed: 28639421
Glia. 2014 Jul;62(7):1075-92
pubmed: 24652679
EMBO J. 2018 Jun 15;37(12):
pubmed: 29789389
Medicine (Baltimore). 2016 Feb;95(8):e2883
pubmed: 26937925
JAMA Neurol. 2018 Aug 1;75(8):939-946
pubmed: 29710331
Elife. 2016 Jan 29;5:
pubmed: 26824392
Sci Transl Med. 2018 Jun 6;10(444):
pubmed: 29875204
Eur J Clin Pharmacol. 2019 Jan;75(1):99-108
pubmed: 30280208
Handb Clin Neurol. 2018;147:211-227
pubmed: 29325612
J Immunol. 2010 Nov 1;185(9):5577-85
pubmed: 20921534
Front Cell Infect Microbiol. 2017 Sep 29;7:435
pubmed: 29034219
J Transl Med. 2019 Jan 22;17(1):37
pubmed: 30670047
J Exp Med. 2017 Oct 2;214(10):3051-3066
pubmed: 28821568
J Leukoc Biol. 2017 Oct;102(4):1093-1102
pubmed: 28751472
Neurology. 2007 Apr 3;68(14):1141-3
pubmed: 17215492
Nat Neurosci. 2014 Jan;17(1):131-43
pubmed: 24316888
J Clin Invest. 2009 Jan;119(1):182-92
pubmed: 19104149
Cell Tissue Res. 2004 Oct;318(1):149-61
pubmed: 15338271
Influenza Other Respir Viruses. 2011 Sep;5(5):328-33
pubmed: 21668692
Neurobiol Dis. 2010 Mar;37(3):510-8
pubmed: 19913097
Int J Mol Sci. 2018 Sep 10;19(9):
pubmed: 30201915
Alzheimers Res Ther. 2017 Mar 4;9(1):14
pubmed: 28259169
Nat Immunol. 2015 Sep;16(9):918-26
pubmed: 26237551
Brain. 2005 Nov;128(Pt 11):2665-74
pubmed: 16219675
Neurology. 2010 Mar 23;74(12):995-1002
pubmed: 20308684
Inflamm Bowel Dis. 2019 Jan 1;25(1):111-123
pubmed: 29788069
J Biol Chem. 2019 Mar 29;294(13):4738-4758
pubmed: 30709905
Gut. 2020 Jan;69(1):193-194
pubmed: 30518530
J Neuroinflammation. 2018 Oct 27;15(1):297
pubmed: 30368241
Hum Mutat. 2010 Jul;31(7):763-80
pubmed: 20506312
J Neuropathol Exp Neurol. 2006 Oct;65(10):953-63
pubmed: 17021400
Neurology. 1988 Aug;38(8):1285-91
pubmed: 3399080
Medicine (Baltimore). 2018 Sep;97(37):e12172
pubmed: 30212946
Hum Mol Genet. 2012 Jun 1;21(11):2420-31
pubmed: 22357653
Neuroscience. 2008 Mar 18;152(2):429-36
pubmed: 18272292
J Neurochem. 2014 Jun;129(6):980-7
pubmed: 24479685
Mol Neurodegener. 2019 Dec 21;14(1):49
pubmed: 31864390
FEBS J. 2015 Aug;282(15):2806-26
pubmed: 25899482
Neuron. 2009 Dec 24;64(6):807-27
pubmed: 20064389
Nat Immunol. 2011 Oct 09;12(11):1063-70
pubmed: 21983832
Neuroscience. 2012 Apr 19;208:41-8
pubmed: 22342962
World J Gastroenterol. 2015 Oct 7;21(37):10609-20
pubmed: 26457021
Neurobiol Dis. 2012 Dec;48(3):582-93
pubmed: 22850484
J Neurosci. 1999 May 1;19(9):3440-7
pubmed: 10212304
Sci Transl Med. 2018 Jan 10;10(423):
pubmed: 29321258
Semin Immunopathol. 2013 Sep;35(5):601-12
pubmed: 23732506
Mov Disord. 2016 Jun;31(6):889-97
pubmed: 26917005
Acta Neuropathol Commun. 2016 Nov 24;4(1):123
pubmed: 27884177
Nat Genet. 2017 Feb;49(2):256-261
pubmed: 28067908
Biochem Biophys Res Commun. 2018 Mar 25;498(1):171-177
pubmed: 29408508
Hum Mol Genet. 2018 Jan 15;27(2):385-395
pubmed: 29177506
PLoS One. 2012;7(4):e34693
pubmed: 22496842
PLoS One. 2012;7(6):e39132
pubmed: 22723946
Nat Neurosci. 2017 Sep;20(9):1300-1309
pubmed: 28758994
J Neurochem. 2009 May;109 Suppl 1:117-25
pubmed: 19393017
J Neurosci. 2012 Feb 1;32(5):1602-11
pubmed: 22302802
Neurology. 2015 Jul 7;85(1):89-95
pubmed: 26062626
Biochem Biophys Res Commun. 2018 Jan 8;495(2):1708-1715
pubmed: 29223392
Neuropathol Appl Neurobiol. 2011 Dec;37(7):777-90
pubmed: 21696411
Brain Struct Funct. 2013 Jul;218(4):1051-60
pubmed: 22886465
J Parkinsons Dis. 2013;3(4):461-91
pubmed: 24252804
Hum Mol Genet. 2013 Mar 1;22(5):1039-49
pubmed: 23223016
Am J Hum Genet. 2013 Nov 7;93(5):984-93
pubmed: 24183452
Proc Natl Acad Sci U S A. 2014 Jun 24;111(25):9289-94
pubmed: 24927544
Neuroscience. 2006;139(3):791-4
pubmed: 16504409
Front Neurol. 2019 Mar 19;10:232
pubmed: 30941089
Dig Liver Dis. 2019 Jan;51(1):38-42
pubmed: 30309751
Acta Neuropathol. 1988;76(6):550-7
pubmed: 2974227
BMJ. 2011 Jan 20;342:d198
pubmed: 21252104
Biofactors. 2012 Nov-Dec;38(6):395-7
pubmed: 22826171

Auteurs

Diego Cabezudo (D)

Laboratory for Neurobiology and Gene Therapy, Department of Neurosciences, KU Leuven, Leuven, Belgium.

Veerle Baekelandt (V)

Laboratory for Neurobiology and Gene Therapy, Department of Neurosciences, KU Leuven, Leuven, Belgium.

Evy Lobbestael (E)

Laboratory for Neurobiology and Gene Therapy, Department of Neurosciences, KU Leuven, Leuven, Belgium.

Classifications MeSH